Evaluation of the Khorana, PROTECHT, and 5-SNP scores for prediction of venous thromboembolism in patients with cancer

N.A.M. Guman*, R.J. van Geffen, F.I. Mulder, T.F. van Haaps, V. Hovsepjan, M. Labots, G.A. Cirkel, F.Y.F.L. de Vos, A.J. ten Tije, L.V. Beerepoot, V.C.G. Tjan-Heijnen, H.W.M. van Laarhoven, P. Hamberg, A.J.E. Vulink, M. Los, A.H. Zwinderman, B. Ferwerda, M.P.J.K. Lolkema, N. Steeghs, H.R. BullerP.W. Kamphuisen, N. van Es

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)2974-2983
Number of pages10
JournalJournal of Thrombosis and Haemostasis
Volume19
Issue number12
Early online date6 Sep 2021
DOIs
Publication statusPublished - Dec 2021

Keywords

  • neoplasms
  • polymorphism
  • risk assessment
  • single nucleotide
  • thrombosis
  • venous thromboembolism
  • RISK PREDICTION
  • CHEMOTHERAPY
  • GUIDELINES
  • MODEL

Cite this